Israel National NewsHealth
Genomic Advances Revolutionize Breast Cancer Screening and Treatment
Summarized from Israel National News by baba
RightCharged tone
Genomic technologies are revolutionizing breast cancer care by enabling personalized treatments based on a tumor's molecular "fingerprint." In Israel, about 5,500 cases are diagnosed yearly, with mortality declining due to early screening and advanced therapies. Genomic tests like Oncotype DX help determine the need for chemotherapy in early stages, while advanced profiling guides targeted treatments for metastatic disease, improving outcomes and quality of life.
The story in 5 lines · by baba
- Genomic technologies enable personalized breast cancer treatments based on individual tumor molecular profiles.
- Screening tests and genomic profiling are crucial for early detection and guiding therapy decisions.
- The Oncotype DX test helps identify early-stage breast cancer patients who can safely forgo chemotherapy.
- Advanced genomic analysis guides targeted therapies for advanced breast cancer, prolonging life.
- Liquid biopsy offers a less invasive method for tumor molecular characterization and treatment matching.
Israel National News publishes in English. The key points are summarized above. Read Israel National News’s full report from the link at the top of the page.